Liquid chromatography-Tandem mass spectrometry or auomated immunoassays: What are the future trends in therapeutic drug monitoring?

Clinical Chemistry

Volumn 58, Issue 5, 2012, Pages 821-825

  Brandhorst, Gunnar ^a   Oellerich, Michael ^a   Maine, Gregory ^b   Taylor, Paul ^c   Veen, Gerhard ^d   Wallemacq, Pierre ^e  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b ABBOTT LABORATORIES   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d Roche Diagnostics Ltd   (Switzerland)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; RAPAMYCIN; TACROLIMUS;

ACCURACY; ANALYTIC METHOD; ANALYTICAL ERROR; CALIBRATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG MONITORING; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; LABORATORY AUTOMATION; LABORATORY DEVICE; LABORATORY TEST; LIQUID CHROMATOGRAPHY; NOTE; PRACTICE GUIDELINE; PRECIPITATION; QUANTITATIVE ASSAY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; STANDARDIZATION; TANDEM MASS SPECTROMETRY; TURNAROUND TIME; VALIDITY;

AUTOANALYSIS; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; HUMANS; IMMUNOASSAY; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 84860677328     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.167189     Document Type: Note

References (0)